Atopix Therapeutics
Latest round
- Series A
Last raised
- Jul 2014
Total raised
- $10M
Investors
- 6
About Atopix Therapeutics
Established in 2012 and based in UK, Atopix Therapeutics Ltd is a biopharmaceutical company that develops oral anti-allergic medicines to treat asthma, chronic allergic conditions and other atopic diseases.
Who invested in Atopix Therapeutics
6 investors across 2 rounds
See all investors in Atopix Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Atopix Therapeutics
Who invested in Atopix Therapeutics?
Atopix Therapeutics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Atopix Therapeutics raised?
Atopix Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Atopix Therapeutics last raise money?
Atopix Therapeutics's most recent round on record is a Series A, in Jul 2014.
What does Atopix Therapeutics do?
Established in 2012 and based in UK, Atopix Therapeutics Ltd is a biopharmaceutical company that develops oral anti-allergic medicines to treat asthma, chronic allergic conditions and other atopic diseases.
Where is Atopix Therapeutics headquartered?
Atopix Therapeutics is headquartered in Abingdon, UK.
Which VCs invest in companies like Atopix Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Atopix Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Atopix Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.